SlideShare a Scribd company logo
1 of 65
Bronchial Asthma presentation
Michael Kino
MBBS,NEIGRIHMS
Bronchial asthma
• Asthma is a chronic inflammatory
disorder of the conducting airways,
usually caused by an immunologic
reaction, which is marked by episodic
bronchoconstriction due to increased
airway sensitivity to a various stimuli;
and increased mucou production.
Bronchial Asthma
#OVERVIEW;
1)Chronic inflammation of airways
2)Increased reaction of
Tracheobronchial tree to different
allergen.
Bronchial Asthma
• Generalized airway obstruction
• Clinically
– Dyspnea, cough & wheezing
– Few minute to hours
– Days (status asthmaticus)
Prevalence and etiology
• 4-5% USA
• Africa, USA and Spain
• All ages, more in childhood
– 50% >10 years
– 1/3 >40years
– Male/Female ratio 2:1 in childhood
– 30 year the ratio is equal
Continue
• Heterogeneous disease
– Atopic
– Genetic & environmental like virus
– Allergen
– Occupational
• Allergic asthma (Atopy)
– History of familial of personal allergy
– Positive skin reaction
– Increased IgE in serum
• Idiosynchronatic asthma (non atopic)
– No familial history
– IgE is negative
– Negative skin tests
Asthma triggers
• Allergen
• Pharmacologic
• Environmental and air pollution
• Occupational
• Infection
• Sport & exercise
• Emotional stress
Allergen
• It is due to IgE reaction which is
controlled with T& B lymphocytes.
• 25-35%
• 1/3 supportive rule
• Allergic asthma is belong to season
• Non seasonal is due to:
– Animal danders, dust, etc
Cont..
• After inhalation of allergens 
• cross reaction of antigen & antibody on
mast cells 
• excretion of hypersensitivity mediators
Pharmacologic
• Aspirin
• Tartrazin
• β-adrenergic antagonists
– Timolol eye drop
Cont..
– Aspirin & other NSAID
• Vasomotor rhinitis
• Hyperplasticrhinosinusitis & nasal polyp
• Bronchial asthma
• Eye & nasal congestion and acute attack of asthma
• Acetaminophen, Sodiumsalicylate,
Cholinesalicylate, Salicylamide & Propoxyphene
well tolerated.
Cont..
–Food
–Detergent and protective:
• Sodium & potassium bisulfate,
• Sulferdioxide
• Potassium metabisulfite
• Sodium sulfate
Environment and Air Pollution
• Air pollution
– Ozone
– Nitrogendioxide
– Sulfur dioxide
• Atmospheric antigen
• Prophylaxis treatment with anti
inflammatory drugs
Occupational Factors
• Several substances found in the workplace may
causes acute or chronic airway obstruction.
• Heavy molecular
– Dust, wood, plants, medicine (antibiotics, peprazin,
cimitidin, biologic enzymes, animal secretion)
• Low molecular
– Inorganic salts (Chrome, Nickel, platinum)
– Chemical & industrial substances
– Plastics (Toluene diisocyanate, Persulfates,
Phatalic acid anhydrase & ethylinediamine)
– Farmaldehyde & Ureaforaldehyde
Infections
• The most common is Resp. Virus
• Child – adults:
– Res. Scyntial virus, parainfluenza
• Adults:
– Influenza, Rhinovirus
– Mechanism not clear but:
• Cytokine Production of T cell
Sport & Exercise
• Causes
• acute attack of asthma
• No long term effect & bronchospasm
• Run/walking
• Cold weather
• Mechanism:
– Hyperemia & vascular leakage of
respiratory system during exercise
Emotional stress
• Worse/better
• Psychological effect is not clear
• Different from one pts to other
• From one attack to other
Pathology
• Necropsy:
– Over distended & non colllapsing lung
– Plugs, exudates in bronches & bronchiols
– Histologic exam:
• Hyperplasia of vascular and submucusal
• Mucusal edema, basement membran thickness
• Esonophils
Pathophysiology
• Airway narrowing due to:
– Smooth muscle contraction
– Vascular congestion
– Bronchus edema
– Thick secretion
• ↑ airway resistance
• ↓ force expiratory volume and PEFR
• Hyper inflate lung and chest
• Changes in respiratory muscle, ventilation,
circulation and gas saturation
– FEV1 < 40% normal
– RV 400%
– Hypoxia is present in acute exacerbation,
but Respiratory failure is present 10-15%
– Normal PCO2:
• is occur with sever resp. obstruction,
• Sign for Respiratory failure
– Metabolic acidosis is occur latter
Clinical finding
• Dyspnea, cough & wheezing
• Typically attack start:
– Chest tightness with dry cough
– Harsh respiration
– wheezing with respiration
– Prolonged expiration period
Cont..
– Tachycardia
– Tachypnia
– Moderate HTN
– Overinflated lung
– paradoxical pulse
– Increased AP diameter of the chest
– Use of resp. accessory muscles
– Wheezing is not the end of attack
Conti..
• The end of attack is specified by:
• productive cough Curschmann’s spiralis:
• (Charcot-Leyden crystal and Eosinophil)
• In sever cases
– Wheezing is decreased or absent, gasping
type respiration,
• Mucoid plug aggregation & suffocation
Continue
– Need for mechanical ventilation
– Some time:
• Atelectasis due to thick secretion
– Rarely
• Spanteneous pneumothorax
• Pneumo mediastinum
Chest-X-Ray
• Early stage
• Late stage or sever
– Hyper-inflation
• Sever case
– pneumothorax
DDx:
• Dyspnea, wheeze
• Periodic attack
• History of allergy
– Eczema, Rhinitis & Urticaria
• Night wakeness
– with dyspnea & wheezing
– Without those phenomena Dx of asthma is not
reliable.
Cont..
• Upper airway obstruction due to Tumor
and laryngeal edema
– Stridor, harsh breathing sounds in larynx
– No generalized wheezing in both lungs
– If Dx is difficult
• Bronchoscopy & Laryngoscopy
cont
• Functional glott dysfunction
– Narrowing of glott in inspi/expir
– Cause periodic sever attack of airway obstruction
– PO2 is normal
– Normal physical finding during attack
Cont..
• Local & continuous wheezing in chest
with cough
– Foreign body aspiration
– Neoplasm or
– Bronchial stenosis
Cont..
• Acute left ventricular failure
– Basal rals
– Gallop rhythm
– Cough with bloody sputum
Conti.
• Recurrent bronchospasm
– Carcinoid tumurs
– Recurrent pul. Emboli & chronic bronchitis
• Eosinophilic pneumonia
• Pneumonia due to chemical
• insecticide &
• Cholinergic drugs
Dx
• Reversible airway obstruction
• Reversibility >15% in FEV1 after 2puff of
β-adrenergic agonist
• If spirometry is normal
– Histamin, methicholin or hyperventilation
– Positive skin reaction
– Esonophilia in blood and sputum
– IgE evaluation in serum
– Chest-X-Ray is not specific
Complications
• Dehydration, Respiratory infection
• CPC, Tussive syncope
• Sever cases (Resp. failure)
• Spontaneous pneumothorax
• Mediastinum emphysema
• Sever reaction  death
– Drugs (penicillin, Aspirin, Indomethacin &
Radiopaque)
Treatment
• Allergic asthma
– Isolation of causative ingredient
– Desensitization
Cont..
• Quick relief medications
– β-adrenergic agonist
– methylxanthines
– Anticholinergics
Cont..
• Long term control medications
– Glucocorticoid
– long acting β2- agonist &
– Combined,
– Leukotriene modifiers &
– Methylxanthines
Quick relief medications
• β-adrenergic agonist:
– Catecholamins
– Resorcinols
– Saligenins
• Causes stimulation of β-adrenergic  activate
G-Proteins  Cyclic adinosin monophosphate 
airway dilatation
• ↓ mediator secretion & ↑ mucus clearance
Quick relief medications
– Catecholamine
• Isoproteronol, Epinephrine & Isoetharine
• 30-90 min IV/Inhalation
– Resorcinol: (Fenoterol, Terbutaline)
– Saligenin: (Albuterol)
– Resorcinol & Saligenin no effect on heart
Cont…
• Side effect:
– Tremor
• Half life (4-6)hour
• Butter to use inhalation
• Long acting agent:
– Salmeterol & Formeterol (9-12) hour
– Not for acute exacerbation
Methylxanthine
• Theophyllin 5-15µg/mL
• Second line drug
– Clearenc ↓ :
• Old age, Erythromycin and other macrlid, Quinolone,
Troleadomycin, Allopurinol, Cimetidine & Propranolol
– Clearenc ↑:
• smooking, Marijuana, Phenobarbital, Phenytoin
Cont..
– Complication:
– anorexia
– nausia & vomiting
– headach
– nervousness
– 30µg/mL cause cardiac arrhythmia
Anticholinergic
• Ipratropium bromide
– Use in concomitant cardiac patient
– Slow effect
• 60-90 min for bronchdilatation
– Moderate bronchodilatation
Glucocorticoids
• The most effective anti inflammatory
drug
• In acute patient when bronchodilator is
not effective
• Failure to other treatment &
• Recurrent exacerbation
Cont..
• Inhalation Glucocorticoid for long term
control
• Glucocorticoids are not bronchodilator
• Methylprednisolone 120-180mg /6 hour IV
• Prednisolone 60mg/ 6hour oral
Cont..
• Because it effect after 6 hour, so it should be
used together with bronchodilators.
• Dose:
– After 3-5 days tapering start & continue for 10-12
days
– Continuously alternating day
– Dexamethason is not used for long term
treatment
Inhaled glucocorticoid
• Continuously symptomatic
–Control of inflammation
–Long term prophylaxis
– ↓ need of systemic steroid
– ↓ risk of hospitalization
– ↓ attack of asthma
–Dose
• Not clear, idividual
• Need one week for clinical response, so
not effective in acute stages.
• In sever cases double the dose
Complication of inhaled steriods
• Oral condidiasis
• Dysphonia
• High doses causes
– Adrenal suppression
– Cataract
– Delay growth in children
– Bone metabolic changes
– Purpura
Drug combination
• Steroid + long acting β2-agonist
– Mild & Moderate patient
• Better effect / alone
Mast cell-stabilizing agent
• Cromolyn sodium
• Nedocromil sodium
• Use in atopic asthma
– Recovery of lung function
– ↓ symptoms
– ↓ airway reaction
Cont..
–Rather than steroid when use for
prophylaxis
• Prevent acute attack when face to
antigen, cold wheather, exercise &
chemical substance
Leukotrin modifiers
• New drug for long term prophylaxis
– Chemical mediators & cause asthma symptoms
• Smooth muscle contraction
• ↑ vascular permeability
• ↑ mucus production
• Activate inflammatory cells of Resp. system
Cont..
–Mild persistent asthma
• Zafirlukast 20mg BID P/O
• Zileuton 600mg QIDP/O
• Mantelukast 10mg OD P/O
Desensitization
• Typical allergic asthma
• Miscellaneous agents
– Immunosuppressant agent
• Methotrexate, Colchicin & gold salts
– Acute sever asthma
• Opiate, Sedative & Tranquilizer should be
avoided
• β-adrenergic blocker & Parasympathetic
agonist is contra indicated
• Expectorant & Mucolytic not effective
• Magnesium sulfate is not clear
Special instruction
• Asthma with cardiac disease or
pregnancy
– β2 selective
• Low dose
Exacerbation of asthma
• Mild exacerbation:
– Inhaled β2 adrenergic
• 3-4 hour/ 24-48
• Inhaled steroid double
• If didn’t use should be started
• If not effective
– Course of Oral corticosteroid
Continue
• Moderate-Sever exacerbation:
– O2 therapy 1-3lit/min
– Inhaled β2 agonist
• Metoproterenol 5%-5ml 2ml
• Albuterol 0.5%-5ml 2ml
Cont..
• If not effective in 30min systemic
corticosteroid
• Methyl Prednisolone succinate
0.5mg/kg/6hour IV
• Hydrocortisone 4mg/kg/6hour/ IV
• Anxiolytic & Hypnotic are contra indicated
Indication for hospitalization
• Unresponsive to treatment
• PEFR < 30-40% or < 200ml
• Respiratory acidosis
• ECG abnormality
– Supraventricular arrhythmia
– conduction defect &
– ventricular ectopy
Cont…
• Pneumothorax
• Pneumomediastinum
• Respiratory failure
• Respiratory infection
Status asthmaticus
• Continual & sever asthma which is not
responsive to the treatment.
• Treatment is the same as acute sever asthma
• Role of Aminophylline is not clear
• IV fluid for correction of hydration
Cont..
• If respiratory acidosis occur:
– Intubation &
– mechanical ventilation
– If not effective:
• Sedation
• Segmental bronchial lavage

More Related Content

What's hot (20)

Bronchial asthma management
Bronchial asthma managementBronchial asthma management
Bronchial asthma management
 
Acute Severe Asthma
Acute Severe AsthmaAcute Severe Asthma
Acute Severe Asthma
 
Pneumonia
PneumoniaPneumonia
Pneumonia
 
Diagnosis &amp; management of status asthmaticus
Diagnosis &amp; management of status asthmaticusDiagnosis &amp; management of status asthmaticus
Diagnosis &amp; management of status asthmaticus
 
Management of asthma
Management of asthmaManagement of asthma
Management of asthma
 
Asthma ppt
Asthma pptAsthma ppt
Asthma ppt
 
Asthma
AsthmaAsthma
Asthma
 
Bronchial asthama
Bronchial asthamaBronchial asthama
Bronchial asthama
 
Bronchial Asthma by Dr. Sookun Rajeev Kumar
Bronchial Asthma by Dr. Sookun Rajeev KumarBronchial Asthma by Dr. Sookun Rajeev Kumar
Bronchial Asthma by Dr. Sookun Rajeev Kumar
 
19.bronchial asthma
19.bronchial asthma19.bronchial asthma
19.bronchial asthma
 
Asthma
AsthmaAsthma
Asthma
 
Lecture 5 asthma and copd
Lecture 5  asthma and copdLecture 5  asthma and copd
Lecture 5 asthma and copd
 
Status asthmaticus
Status asthmaticusStatus asthmaticus
Status asthmaticus
 
Bronchial asthma
Bronchial asthmaBronchial asthma
Bronchial asthma
 
Asthma ppt
Asthma pptAsthma ppt
Asthma ppt
 
Gina - global initiative against asthma
Gina - global initiative against asthmaGina - global initiative against asthma
Gina - global initiative against asthma
 
Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease  Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease
 
Asthma
AsthmaAsthma
Asthma
 
Status asthmaticus
Status asthmaticusStatus asthmaticus
Status asthmaticus
 
Asthma
AsthmaAsthma
Asthma
 

Similar to Bronchial Asthma Presentation Overview

Childhood asthma 2021
Childhood asthma 2021Childhood asthma 2021
Childhood asthma 2021Imran Iqbal
 
Allergic diseases
Allergic diseasesAllergic diseases
Allergic diseasesEneutron
 
Asthmatic presentation description pptxy
Asthmatic presentation description pptxyAsthmatic presentation description pptxy
Asthmatic presentation description pptxyAmos830559
 
4_6012490482486085206.pdf
4_6012490482486085206.pdf4_6012490482486085206.pdf
4_6012490482486085206.pdfismaeljemal1
 
5. Bronchial asthma treatment and prognosis .pdf
5. Bronchial asthma  treatment and prognosis  .pdf5. Bronchial asthma  treatment and prognosis  .pdf
5. Bronchial asthma treatment and prognosis .pdfShinilLenin
 
cough-161117122251 (1).pdf
cough-161117122251 (1).pdfcough-161117122251 (1).pdf
cough-161117122251 (1).pdfTabassum Saher
 
Asthma presentation
Asthma presentationAsthma presentation
Asthma presentationHome
 
Pulmonary Diseases 2009 copy
Pulmonary Diseases 2009 copyPulmonary Diseases 2009 copy
Pulmonary Diseases 2009 copyIAU Dent
 
Pulmonary Diseases
Pulmonary DiseasesPulmonary Diseases
Pulmonary DiseasesIAU Dent
 
BRONCHIAL ASTHMA.ppt
BRONCHIAL ASTHMA.pptBRONCHIAL ASTHMA.ppt
BRONCHIAL ASTHMA.pptBijayaSaha5
 
3. Asthma-1.pptx
3. Asthma-1.pptx3. Asthma-1.pptx
3. Asthma-1.pptxSalimMumba
 

Similar to Bronchial Asthma Presentation Overview (20)

BRONCHIAL ASTHMA.pptx
BRONCHIAL ASTHMA.pptxBRONCHIAL ASTHMA.pptx
BRONCHIAL ASTHMA.pptx
 
Childhood asthma 2021
Childhood asthma 2021Childhood asthma 2021
Childhood asthma 2021
 
Asthma
AsthmaAsthma
Asthma
 
Bronchial Asthma.pptx
Bronchial Asthma.pptxBronchial Asthma.pptx
Bronchial Asthma.pptx
 
Allergic diseases
Allergic diseasesAllergic diseases
Allergic diseases
 
Bronchial-Asthma.pdf
Bronchial-Asthma.pdfBronchial-Asthma.pdf
Bronchial-Asthma.pdf
 
Asthmatic presentation description pptxy
Asthmatic presentation description pptxyAsthmatic presentation description pptxy
Asthmatic presentation description pptxy
 
4_6012490482486085206.pdf
4_6012490482486085206.pdf4_6012490482486085206.pdf
4_6012490482486085206.pdf
 
5. Bronchial asthma treatment and prognosis .pdf
5. Bronchial asthma  treatment and prognosis  .pdf5. Bronchial asthma  treatment and prognosis  .pdf
5. Bronchial asthma treatment and prognosis .pdf
 
cough-161117122251 (1).pdf
cough-161117122251 (1).pdfcough-161117122251 (1).pdf
cough-161117122251 (1).pdf
 
Cough
CoughCough
Cough
 
Asthma
Asthma Asthma
Asthma
 
Asthma presentation
Asthma presentationAsthma presentation
Asthma presentation
 
ASTHMA LECTURE.pptx
ASTHMA LECTURE.pptxASTHMA LECTURE.pptx
ASTHMA LECTURE.pptx
 
Pulmonary Diseases 2009 copy
Pulmonary Diseases 2009 copyPulmonary Diseases 2009 copy
Pulmonary Diseases 2009 copy
 
Pulmonary Diseases
Pulmonary DiseasesPulmonary Diseases
Pulmonary Diseases
 
Childhood Asthma.pptx
Childhood Asthma.pptxChildhood Asthma.pptx
Childhood Asthma.pptx
 
BRONCHIAL ASTHMA.ppt
BRONCHIAL ASTHMA.pptBRONCHIAL ASTHMA.ppt
BRONCHIAL ASTHMA.ppt
 
Asthma
Asthma Asthma
Asthma
 
3. Asthma-1.pptx
3. Asthma-1.pptx3. Asthma-1.pptx
3. Asthma-1.pptx
 

Recently uploaded

BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsKarinaGenton
 
Painted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaPainted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaVirag Sontakke
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️9953056974 Low Rate Call Girls In Saket, Delhi NCR
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting DataJhengPantaleon
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Celine George
 
internship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerinternship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerunnathinaik
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon AUnboundStockton
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfMahmoud M. Sallam
 
Class 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdfClass 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdfakmcokerachita
 
Biting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfBiting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfadityarao40181
 
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxEPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxRaymartEstabillo3
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxOH TEIK BIN
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Krashi Coaching
 

Recently uploaded (20)

BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its Characteristics
 
Painted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaPainted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of India
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application )
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
 
Staff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSDStaff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSD
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17
 
internship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerinternship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developer
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon A
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdf
 
Class 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdfClass 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdf
 
Biting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfBiting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdf
 
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxEPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptx
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 

Bronchial Asthma Presentation Overview

  • 2. Bronchial asthma • Asthma is a chronic inflammatory disorder of the conducting airways, usually caused by an immunologic reaction, which is marked by episodic bronchoconstriction due to increased airway sensitivity to a various stimuli; and increased mucou production.
  • 3. Bronchial Asthma #OVERVIEW; 1)Chronic inflammation of airways 2)Increased reaction of Tracheobronchial tree to different allergen.
  • 4. Bronchial Asthma • Generalized airway obstruction • Clinically – Dyspnea, cough & wheezing – Few minute to hours – Days (status asthmaticus)
  • 5. Prevalence and etiology • 4-5% USA • Africa, USA and Spain • All ages, more in childhood – 50% >10 years – 1/3 >40years – Male/Female ratio 2:1 in childhood – 30 year the ratio is equal
  • 6. Continue • Heterogeneous disease – Atopic – Genetic & environmental like virus – Allergen – Occupational
  • 7. • Allergic asthma (Atopy) – History of familial of personal allergy – Positive skin reaction – Increased IgE in serum • Idiosynchronatic asthma (non atopic) – No familial history – IgE is negative – Negative skin tests
  • 8. Asthma triggers • Allergen • Pharmacologic • Environmental and air pollution • Occupational • Infection • Sport & exercise • Emotional stress
  • 9. Allergen • It is due to IgE reaction which is controlled with T& B lymphocytes. • 25-35% • 1/3 supportive rule • Allergic asthma is belong to season • Non seasonal is due to: – Animal danders, dust, etc
  • 10. Cont.. • After inhalation of allergens  • cross reaction of antigen & antibody on mast cells  • excretion of hypersensitivity mediators
  • 11. Pharmacologic • Aspirin • Tartrazin • β-adrenergic antagonists – Timolol eye drop
  • 12. Cont.. – Aspirin & other NSAID • Vasomotor rhinitis • Hyperplasticrhinosinusitis & nasal polyp • Bronchial asthma • Eye & nasal congestion and acute attack of asthma • Acetaminophen, Sodiumsalicylate, Cholinesalicylate, Salicylamide & Propoxyphene well tolerated.
  • 13. Cont.. –Food –Detergent and protective: • Sodium & potassium bisulfate, • Sulferdioxide • Potassium metabisulfite • Sodium sulfate
  • 14. Environment and Air Pollution • Air pollution – Ozone – Nitrogendioxide – Sulfur dioxide • Atmospheric antigen • Prophylaxis treatment with anti inflammatory drugs
  • 15. Occupational Factors • Several substances found in the workplace may causes acute or chronic airway obstruction. • Heavy molecular – Dust, wood, plants, medicine (antibiotics, peprazin, cimitidin, biologic enzymes, animal secretion)
  • 16. • Low molecular – Inorganic salts (Chrome, Nickel, platinum) – Chemical & industrial substances – Plastics (Toluene diisocyanate, Persulfates, Phatalic acid anhydrase & ethylinediamine) – Farmaldehyde & Ureaforaldehyde
  • 17. Infections • The most common is Resp. Virus • Child – adults: – Res. Scyntial virus, parainfluenza • Adults: – Influenza, Rhinovirus – Mechanism not clear but: • Cytokine Production of T cell
  • 18. Sport & Exercise • Causes • acute attack of asthma • No long term effect & bronchospasm • Run/walking • Cold weather • Mechanism: – Hyperemia & vascular leakage of respiratory system during exercise
  • 19. Emotional stress • Worse/better • Psychological effect is not clear • Different from one pts to other • From one attack to other
  • 20. Pathology • Necropsy: – Over distended & non colllapsing lung – Plugs, exudates in bronches & bronchiols – Histologic exam: • Hyperplasia of vascular and submucusal • Mucusal edema, basement membran thickness • Esonophils
  • 21. Pathophysiology • Airway narrowing due to: – Smooth muscle contraction – Vascular congestion – Bronchus edema – Thick secretion • ↑ airway resistance • ↓ force expiratory volume and PEFR • Hyper inflate lung and chest • Changes in respiratory muscle, ventilation, circulation and gas saturation
  • 22. – FEV1 < 40% normal – RV 400% – Hypoxia is present in acute exacerbation, but Respiratory failure is present 10-15% – Normal PCO2: • is occur with sever resp. obstruction, • Sign for Respiratory failure – Metabolic acidosis is occur latter
  • 23. Clinical finding • Dyspnea, cough & wheezing • Typically attack start: – Chest tightness with dry cough – Harsh respiration – wheezing with respiration – Prolonged expiration period
  • 24. Cont.. – Tachycardia – Tachypnia – Moderate HTN – Overinflated lung – paradoxical pulse – Increased AP diameter of the chest – Use of resp. accessory muscles – Wheezing is not the end of attack
  • 25. Conti.. • The end of attack is specified by: • productive cough Curschmann’s spiralis: • (Charcot-Leyden crystal and Eosinophil) • In sever cases – Wheezing is decreased or absent, gasping type respiration, • Mucoid plug aggregation & suffocation
  • 26. Continue – Need for mechanical ventilation – Some time: • Atelectasis due to thick secretion – Rarely • Spanteneous pneumothorax • Pneumo mediastinum
  • 27. Chest-X-Ray • Early stage • Late stage or sever – Hyper-inflation • Sever case – pneumothorax
  • 28. DDx: • Dyspnea, wheeze • Periodic attack • History of allergy – Eczema, Rhinitis & Urticaria • Night wakeness – with dyspnea & wheezing – Without those phenomena Dx of asthma is not reliable.
  • 29. Cont.. • Upper airway obstruction due to Tumor and laryngeal edema – Stridor, harsh breathing sounds in larynx – No generalized wheezing in both lungs – If Dx is difficult • Bronchoscopy & Laryngoscopy
  • 30. cont • Functional glott dysfunction – Narrowing of glott in inspi/expir – Cause periodic sever attack of airway obstruction – PO2 is normal – Normal physical finding during attack
  • 31. Cont.. • Local & continuous wheezing in chest with cough – Foreign body aspiration – Neoplasm or – Bronchial stenosis
  • 32. Cont.. • Acute left ventricular failure – Basal rals – Gallop rhythm – Cough with bloody sputum
  • 33. Conti. • Recurrent bronchospasm – Carcinoid tumurs – Recurrent pul. Emboli & chronic bronchitis • Eosinophilic pneumonia • Pneumonia due to chemical • insecticide & • Cholinergic drugs
  • 34. Dx • Reversible airway obstruction • Reversibility >15% in FEV1 after 2puff of β-adrenergic agonist • If spirometry is normal – Histamin, methicholin or hyperventilation – Positive skin reaction – Esonophilia in blood and sputum – IgE evaluation in serum – Chest-X-Ray is not specific
  • 35. Complications • Dehydration, Respiratory infection • CPC, Tussive syncope • Sever cases (Resp. failure) • Spontaneous pneumothorax • Mediastinum emphysema • Sever reaction  death – Drugs (penicillin, Aspirin, Indomethacin & Radiopaque)
  • 36. Treatment • Allergic asthma – Isolation of causative ingredient – Desensitization
  • 37. Cont.. • Quick relief medications – β-adrenergic agonist – methylxanthines – Anticholinergics
  • 38. Cont.. • Long term control medications – Glucocorticoid – long acting β2- agonist & – Combined, – Leukotriene modifiers & – Methylxanthines
  • 39. Quick relief medications • β-adrenergic agonist: – Catecholamins – Resorcinols – Saligenins • Causes stimulation of β-adrenergic  activate G-Proteins  Cyclic adinosin monophosphate  airway dilatation • ↓ mediator secretion & ↑ mucus clearance
  • 40. Quick relief medications – Catecholamine • Isoproteronol, Epinephrine & Isoetharine • 30-90 min IV/Inhalation – Resorcinol: (Fenoterol, Terbutaline) – Saligenin: (Albuterol) – Resorcinol & Saligenin no effect on heart
  • 41. Cont… • Side effect: – Tremor • Half life (4-6)hour • Butter to use inhalation • Long acting agent: – Salmeterol & Formeterol (9-12) hour – Not for acute exacerbation
  • 42. Methylxanthine • Theophyllin 5-15µg/mL • Second line drug – Clearenc ↓ : • Old age, Erythromycin and other macrlid, Quinolone, Troleadomycin, Allopurinol, Cimetidine & Propranolol – Clearenc ↑: • smooking, Marijuana, Phenobarbital, Phenytoin
  • 43. Cont.. – Complication: – anorexia – nausia & vomiting – headach – nervousness – 30µg/mL cause cardiac arrhythmia
  • 44. Anticholinergic • Ipratropium bromide – Use in concomitant cardiac patient – Slow effect • 60-90 min for bronchdilatation – Moderate bronchodilatation
  • 45. Glucocorticoids • The most effective anti inflammatory drug • In acute patient when bronchodilator is not effective • Failure to other treatment & • Recurrent exacerbation
  • 46. Cont.. • Inhalation Glucocorticoid for long term control • Glucocorticoids are not bronchodilator • Methylprednisolone 120-180mg /6 hour IV • Prednisolone 60mg/ 6hour oral
  • 47. Cont.. • Because it effect after 6 hour, so it should be used together with bronchodilators. • Dose: – After 3-5 days tapering start & continue for 10-12 days – Continuously alternating day – Dexamethason is not used for long term treatment
  • 48. Inhaled glucocorticoid • Continuously symptomatic –Control of inflammation –Long term prophylaxis – ↓ need of systemic steroid – ↓ risk of hospitalization – ↓ attack of asthma
  • 49. –Dose • Not clear, idividual • Need one week for clinical response, so not effective in acute stages. • In sever cases double the dose
  • 50. Complication of inhaled steriods • Oral condidiasis • Dysphonia • High doses causes – Adrenal suppression – Cataract – Delay growth in children – Bone metabolic changes – Purpura
  • 51. Drug combination • Steroid + long acting β2-agonist – Mild & Moderate patient • Better effect / alone
  • 52. Mast cell-stabilizing agent • Cromolyn sodium • Nedocromil sodium • Use in atopic asthma – Recovery of lung function – ↓ symptoms – ↓ airway reaction
  • 53. Cont.. –Rather than steroid when use for prophylaxis • Prevent acute attack when face to antigen, cold wheather, exercise & chemical substance
  • 54. Leukotrin modifiers • New drug for long term prophylaxis – Chemical mediators & cause asthma symptoms • Smooth muscle contraction • ↑ vascular permeability • ↑ mucus production • Activate inflammatory cells of Resp. system
  • 55. Cont.. –Mild persistent asthma • Zafirlukast 20mg BID P/O • Zileuton 600mg QIDP/O • Mantelukast 10mg OD P/O
  • 56. Desensitization • Typical allergic asthma • Miscellaneous agents – Immunosuppressant agent • Methotrexate, Colchicin & gold salts
  • 57. – Acute sever asthma • Opiate, Sedative & Tranquilizer should be avoided • β-adrenergic blocker & Parasympathetic agonist is contra indicated • Expectorant & Mucolytic not effective • Magnesium sulfate is not clear
  • 58. Special instruction • Asthma with cardiac disease or pregnancy – β2 selective • Low dose
  • 59. Exacerbation of asthma • Mild exacerbation: – Inhaled β2 adrenergic • 3-4 hour/ 24-48 • Inhaled steroid double • If didn’t use should be started • If not effective – Course of Oral corticosteroid
  • 60. Continue • Moderate-Sever exacerbation: – O2 therapy 1-3lit/min – Inhaled β2 agonist • Metoproterenol 5%-5ml 2ml • Albuterol 0.5%-5ml 2ml
  • 61. Cont.. • If not effective in 30min systemic corticosteroid • Methyl Prednisolone succinate 0.5mg/kg/6hour IV • Hydrocortisone 4mg/kg/6hour/ IV • Anxiolytic & Hypnotic are contra indicated
  • 62. Indication for hospitalization • Unresponsive to treatment • PEFR < 30-40% or < 200ml • Respiratory acidosis • ECG abnormality – Supraventricular arrhythmia – conduction defect & – ventricular ectopy
  • 63. Cont… • Pneumothorax • Pneumomediastinum • Respiratory failure • Respiratory infection
  • 64. Status asthmaticus • Continual & sever asthma which is not responsive to the treatment. • Treatment is the same as acute sever asthma • Role of Aminophylline is not clear • IV fluid for correction of hydration
  • 65. Cont.. • If respiratory acidosis occur: – Intubation & – mechanical ventilation – If not effective: • Sedation • Segmental bronchial lavage